Pharmaxis Ltd (PMXSF) Stock Analysis
DELISTED
What happened to Pharmaxis Ltd (PMXSF) stock?
Pharmaxis Ltd (PMXSF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $31.0M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Pharmaxis Ltd (PMXSF). Pharmaxis Ltd is an Australian biopharmaceutical company focused on developing and commercializing treatments for fibrotic and inflammatory diseases. Its key products include Bronchitol for cystic fibrosis and Aridol for asthma diagnosis.
Last analyzed: Mar 17, 2026Pharmaxis Ltd (PMXSF) Healthcare & Pipeline Overview
PMXSF OTC Market Information
PMXSF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy PMXSF shares?
No. PMXSF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for PMXSF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PMXSF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Pharmaxis Ltd. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.